IbTX appeared to specifically attenuate tumorigenicity in breast cancer models by transmembrane depolarization and downregulation of β-catenin and (phospho)Akt and HER-2/neu protein levels [135] (Table 1). This evidence concerns the gene ERBB2 and breast carcinoma.